- Conditions
- Influenza
- Interventions
- NanoFlu, Fluzone HD - Day 0, Fluzone HD - Day 21, Saline - Day 21
- Biological · Other
- Lead sponsor
- Novavax
- Industry
- Eligibility
- 60 Years and older
- Enrollment
- 330 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2018
- U.S. locations
- 3
- States / cities
- Raleigh, North Carolina • Rocky Mount, North Carolina • Statesville, North Carolina
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Influenza, Human
- Interventions
- NanoFlu, Fluzone Quadrivalent
- Biological
- Lead sponsor
- Novavax
- Industry
- Eligibility
- 65 Years and older
- Enrollment
- 2,654 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 19
- States / cities
- Hollywood, Florida • Savannah, Georgia • Stockbridge, Georgia + 16 more
- Conditions
- Influenza, Human
- Interventions
- NanoFlu (Quad-NIV), Matrix-M Adjuvant, Placebo, Fluzone HD, Flublok Quadrivalent, Influenza Vaccine
- Biological · Other
- Lead sponsor
- Novavax
- Industry
- Eligibility
- 65 Years and older
- Enrollment
- 1,375 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2019
- U.S. locations
- 14
- States / cities
- Hollywood, Florida • Savannah, Georgia • Stockbridge, Georgia + 11 more